- IFS 2021 access closed!
IFS 2021 is now closed
Need an extension?
Have all 16 CEU/PDA approved IFS 2021 courses (total 36 hours) manually added to your healthyseminars.com account that grants you an additional one (1) year access for CEU / PDA / CPDs completion and unlimited, lifetime access* to materials (handouts and recordings) for future reference and continued review. Click here
This is an on-demand course, there are only distance CEUs
|2 CEU||2 CEU||2 CEU|
|Credits||2 CE||2 CE|
Endometriosis is a complicated chronic inflammatory condition. When patients are successful at conceiving, some are able to improve their endometriosis whilst others find it worsens and can develop into adenomyosis. Both conditions require a few key etiological considerations for treatment that reflect the sophistication and complexity of the conditions. Endometriosis and adenomyosis are both multifactorial and comprehensive by nature and are often simplified by clinicians which produce poor outcomes and reduced treatment success. The interplay between many aspects including the immune system, infective triggers, peritoneal fluid and the endocannabinoid system can have profound impact to the microbiome, methylation, epigenetics, inflammatory processes and endocrinological variables important in the progression and escalation of these conditions.
- Participants will understand the role of the immune system and infective drivers in both the development and prevention of adenomyosis and endometriosis
- Participants will understand the interrelationship of the immune system and infective drivers and their roles in inter-generational health outcomes
- Participants will understand the inflammatory nature of the conditions and the subsequent impact to the peritoneal fluid, epigenetic drivers and methylation corruption
- Participants will acquire strategic and sophisticated treatment strategies to effectively manage their patients’ health and prevent recurrence or progression of these diseases